Drug Shortage Report for SERTRALINE
Report ID | 135815 |
Drug Identification Number | 02353520 |
Brand name | SERTRALINE |
Common or Proper name | SERTRALINE |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | SERTRALINE |
Strength(s) | 25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-05-28 |
Actual start date | 2021-06-02 |
Estimated end date | 2021-07-30 |
Actual end date | 2021-08-03 |
Shortage status | Resolved |
Updated date | 2021-08-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-08-04 | English | Compare |
v8 | 2021-08-03 | French | Compare |
v7 | 2021-08-03 | English | Compare |
v6 | 2021-06-03 | English | Compare |
v5 | 2021-06-02 | French | Compare |
v4 | 2021-06-02 | English | Compare |
v3 | 2021-05-29 | English | Compare |
v2 | 2021-03-17 | French | Compare |
v1 | 2021-03-17 | English | Compare |
Showing 1 to 9 of 9